A detailed history of Builder Investment Group Inc /Adv transactions in Abb Vie Inc. stock. As of the latest transaction made, Builder Investment Group Inc /Adv holds 2,333 shares of ABBV stock, worth $418,073. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,333
Previous 2,333 -0.0%
Holding current value
$418,073
Previous $400 Million 15.14%
% of portfolio
0.12%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $15,982 - $18,210
100 Added 4.48%
2,333 $425 Million
Q4 2022

Feb 24, 2023

BUY
$138.31 - $165.87 $308,846 - $370,387
2,233 New
2,233 $361 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Builder Investment Group Inc /Adv Portfolio

Follow Builder Investment Group Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Builder Investment Group Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Builder Investment Group Inc /Adv with notifications on news.